Felix Mahfoud
Declaration of interest
| Function | Company |
|---|---|
| Grants/research support | Medtronic |
| Other | Medtronic |
Latest contributions
How to perform safe and effective renal denervation
20 Sep 2024
Following the recent inclusion of renal denervation as an approved therapy in the 2023 European Society of Hypertension guidelines, Andrew Sharp and Felix Mahfoud discuss patient selection (for those with resistant hypertension or uncontrolled blood pressure), setting up best practices, the safe and appropriate use of contrast, choosing...
A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension
13 Nov 2024
Lucas Lauder and Felix Mahfoud provide a summary of the ESC Guidelines on elevated blood pressure and hypertension presented by John William McEvoy and Rhian Touyz at ESC Congress 2024 in London.
Author
Author
uRDN now - The third pillar for hypertension treatment
16 May 2024 – From EuroPCR 2024
Tune into this session to stay updated on the cutting-edge clinical evidence, guidelines, and technology surrounding renal denervation. Explore firsthand clinical experiences with ultrasound renal denervation and gain practical insights into patient selection through individual, real-world case discussions. Engage in discussions on integrating ultrasound renal denervation...
Why mechanical thrombectomy should be considered in the management of acute pulmonary embolism
16 May 2024 – From EuroPCR 2024
In this EuroPCR 2024 session, study the case of a patient with high-risk pulmonary embolism and another with intermediate to high-risk pulmonary embolism, delve into discussions on clinical evidence for mechanical thrombectomy in pulmonary embolism, acquire skills to evaluate eligibility for mechanical thrombectomy, and learn how to...
Trial updates and featured clinical research
16 May 2024 – From EuroPCR 2024
This session showcases a selection of the latest clinical research and trial updates presented at EuroPCR 2024. Attendees will have the opportunity to learn about the findings from studies evaluating the use of OCT-guided PCI for chronic total occlusions, the safety and efficacy of short dual...
Cardiovascular intervention for chronic heart failure: where do we stand?
15 May 2024 – From EuroPCR 2024
Devices in pulmonary embolism - Why you should be interested!
15 May 2024 – From EuroPCR 2024
This session provides a comprehensive overview of device-based pulmonary embolism treatment. Experts will discuss the clinical problem of pulmonary embolism, the importance of forming a dedicated team, and the available devices and their characteristics. The session will also feature case-based discussions on the use of catheter-directed...
Renal denervation step by step: how to perform a safe and effective procedure
14 May 2024 – From EuroPCR 2024
This session provides a comprehensive overview of renal denervation, covering the essential aspects of patient selection, preprocedural assessment and imaging, the technical steps for performing safe and effective radiofrequency and ultrasound-based renal denervation, and the importance of post-procedural follow-up. The discussions aim to equip the audience...
Align for the future with next-generation balloon expandable transcatheter heart valve technology
14 May 2024 – From EuroPCR 2024
Tune in to this EuroPCR 2024 session to explore the Myval Octacor THV, a cutting-edge balloon-expandable transcatheter heart valve. Discover its advanced features, potential clinical benefits, and procedural impact. Learn about the latest updates on the Myval THV series and the LANDMARK RCT. Explore the OctaAlign technique for...
Innovations in cardiovascular interventions for chronic heart failure: where are we in 2024?
15 May 2024 – From EuroPCR 2024
Is there an ongoing need for interventions in chronic heart failure? At ACC, a significant trial unveiled interatrial shunting. What does this mean for patients? Explore the devices involved in neuromodulation and considerations for patient discussions. Who might benefit from intravascular monitoring? Watch Giuseppe Rosano and...
Innovations in renal denervation: deja vu or reality?
13 May 2024 – From EuroPCR 2024
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
Current trends in the invasive treatment of pulmonary embolism
18 May 2023 – From EuroPCR 2023
Embark on an exploration of the current trends in the invasive treatment of pulmonary embolism. Grasp the intricacies of establishing a catheter intervention service, navigate patient selection for advanced devices like catheter-directed thrombolysis and mechanical thrombectomy, and stay ahead by reviewing the latest clinical trials in...
Get ready – how to set up a successful renal denervation programme
18 May 2023 – From EuroPCR 2023
Delve into the essentials of renal denervation. Explore current evidence, program setup strategies, and building a multidisciplinary hypertension team.
Innovations in device-based treatment for hypertension
17 May 2023 – From EuroPCR 2023
Join this session to explore the latest innovations in device-based treatment for hypertension. Gain a comprehensive understanding of the evidence supporting the efficacy, durability, and safety of radiofrequency renal denervation, learn from renowned experts about the renal denervation procedure and receive valuable insights on patient selection...
REVIVED: will this trial change my practice?
17 May 2023 – From EuroPCR 2023
Within this collection of slides, acquire insights into the efficient management of patients with ischaemic heart disease and the identification of those who may benefit from revascularisation. Delve into a thorough review of the REVIVED trial, encompassing its methods, results, and conclusions.
Patient selection for renal denervation in 2023
17 May 2023 – From EuroPCR 2023
While many clinical studies have demonstrated the superiority of renal denervation, the question that Felix Mahfoud asks Michel Azizi is when and in which patients to use this technique. Referring to the new consensus guidelines, our hypertension expert provides some answers in this exclusive interview recorded during EuroPCR 2023....
From proof to practice - Treating hypertension with ultrasound renal denervation
16 May 2023 – From EuroPCR 2023
Renal denervation: what are the latest clinical evidences and benefits? How to select the good candidate? How to establish a dedicated centre? All the anwers to these questions and more in this video.
Comeback of renal denervation: The ESC Council on hypertension/EAPCI clinical consensus statement
16 May 2023 – From EuroPCR 2023
Ready to rejuvenate your memory of this session tackling on renal denervation? Investigate these slides and review the take home messages.
Innovations in Heart Failure: Pumps, Remodeling and Monitoring
15 May 2023 – From PCR Innovators Day 2023
Coronary clinical cases - session 1
03 Mar 2023 – From AfricaPCR 2023
This AfricaPCR 2023 session will enable you to study several cases, including that of a 66-year-old male patient with atrial fibrillation, hypothyroidism, previous PCI of RCA, LM to LAD and OM, who was admitted for NSTEMI. Watch the video to find out more!
Renal denervation for treatment of hypertension – heading for new shore
19 Jul 2022
View this replay of a LIVE Round Table Webinar - Renal denervation for treatment of hypertension - with F. Mahfoud, A. Pathak, K. Tsioufis and T. Zellera
Late-breaking science overview - What did we learn @EuroPCR 2022?
20 May 2022 – From EuroPCR 2022
Watch this video to gain insight into late-breaking studies and trials presented during EuroPCR 2022:
- Intravascular imaging vs. angiography-guided PCI in high bleeding risk patients
- Trancatheter Aortic Valve Repair for aortic insufficiency using the Cusper device
- Angiography-derived coronary microcirculatory assessment in INOCA patients
- Blood pressure and MACE reductions after renal...
Is PCI enough in STEMI?
18 May 2022 – From EuroPCR 2022
With study results and case presentations, in this EuroPCR 2022 session, our experts try to demonstrate the need for improved outcomes in STEMI, and enable you to understand how infarct size and microvascular obstruction impact these outcomes, and to learn about SuperSaturated Oxygen Therapy and the data supporting infarct...
Daily news
17 May 2022 – From EuroPCR 2022
EuroPCR 2022 Hotlines / Late-Breaking Trials in hypertension management: SPYRAL-HTN ON MED, radiance HTN SOLO and TRIO, and more!
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in hypertension management! Blood pressure and MACE reductions after renal denervation: 3-year GSR results, patient-level pooled analysis of ultrasound RDN in radiance-HTN SOLO and Trio, and SPYRAL-HTN ON MED 3 year data.
Advances in renal denervation: from patient selection to procedure
17 May 2022 – From EuroPCR 2022
For this EuroPCR 2022 session, Felix Mahfoud is joined by David Kandzari, Rasha Al-Lamee, Flavio Ribichini, and Andrew Sharp to talk about renal denervation: hear real-life experiences and get the latest preclinical and clinical data on the long-term safety and efficacy of the radiofrequency renal denervation...
Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation
17 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session, which covers the latest clinical evidence around catheter-based ultrasound renal denervation, will also enable you to appreciate the distinct features of this approach, to understand perspectives on patient selection and patient preference, and to learn how to introduce and establish interventional hypertension therapy.
Hypertension management in 2022: Latest data on renal denervation - EuroPCR 2022
17 May 2022
On the occasion of World Hypertension Day, Felix Mahfoud speaks about the value of renal denervation, including the latest data and what we can learn about renal denervation at EuroPCR 2022.
Author
How does Paradise renal denervation fit into hypertension treatment management?
20 May 2021 – From EuroPCR 2021
Watch this session presented by Felix Mahfoud, Philipp Lurz, Konstantinos Tsioufis and Joachim Weil in order to understand the ultrasound-based renal denervation procedure and summary of the latest clinical data, to review consensus statements and guidelines for the renal denervation therapy today, and to hear expert perspectives on how to establish...
